Tocilizumab-aazg recalls

The FDA has published 1 recall involving Tocilizumab-aazg since 2026. The latest was reported on 2 Sep 2026. Most were for particulate matter. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls1since 2026

Last 12 months1reported

Class I1100% of total

Ongoing1latest 2 Sep 2026

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 1

Severity split

Class I 1 100%Class II 0 0%Class III 0 0%

Why tocilizumab-aazg is recalled

Particulate Matter1100%

Companies

Fresenius Kabi USA1100%

By year

20261100%

Ongoing tocilizumab-aazg recalls

1 active

Reported	Class	Recall	Company	Reason	Where
2 Sep 2026Drug	CLASS I	Tyenne (tocilizumab-aazg) Injection, 400 mg/ (20 mg/mL) vial recalledTyenne	Fresenius Kabi USA	Particulate Matter	Nationwide

All tocilizumab-aazg recalls, newest first

1 total

Reported	Class	Recall	Company	Reason	Where
2 Sep 2026Drug	CLASS I	Tyenne (tocilizumab-aazg) Injection, 400 mg/ (20 mg/mL) vial recalledTyenne	Fresenius Kabi USA	Particulate Matter	Nationwide

Should you stop taking Tocilizumab-aazg?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.